19 December 2022
Fewer long-term investments were made in the companies behind the nuclear weapons industry, according to the Don’t Bank on the Bomb report, published today by PAX and ICAN. The report found a $45.9 billion drop in long-term investments in 2022, including loans and underwriting.
Analysis suggests that the long-term trend “could signal that a growing number of long-term investors do not see nuclear weapon production as a sustainable growth market and regard the companies involved as an avoidable risk. It also reflects the changes in the legal context: Increasingly, mandatory due diligence legislation in Europe, and the anticipation of such laws, is raising questions around investments in arms producers.”
$746,677 million was made available to the nuclear weapons producing companies between January 2020 and July 2022, a $61.5 billion increase from the previous year. The increase can be attributed to an increase in shareholding in 2022 compared to 2021. Bondholding values dropped by $1 billion. Loans and underwriting also decreased with $31.2 billion and $14.7 billion respectively.
306 institutions have financing or investment relationships with the 24 nuclear weapon producing companies.